tetradecanoylphorbol acetate has been researched along with Multiple Myeloma in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bártová, E; Hájek, R; Harnicarová, A; Kozubek, S; Krejcí, J; Kůrová, J; Legartová, S; Uhlírová, R | 1 |
| Jelinek, DF; Wong, TW | 1 |
| Côté, S; Lemieux, R; Simard, C | 1 |
| Hozumi, N; Ikeda, Y; Ito, K; Kizaki, M; Murakami, A; Nakazato, T; Ohigashi, H; Xian, MJ; Yamada, T | 1 |
| Cleaveland, ES; Craig, RW; Eastman, A; Vrana, JA | 1 |
| Adolf, GR; Fischer, P; Haas, OA; Swetly, P | 1 |
| Bennett, M; Fredrickson, GG | 1 |
| Tsan, MF | 1 |
| Berg, A; Le Blanc, K; Palmblad, J; Samuelsson, J | 1 |
| Xiao, D | 1 |
| Antcliff, J; Croucher, PI; Hargreaves, PG; Lawry, J; Murphy, G; Russell, RG; Wang, F | 1 |
| Carbone, A; Drexler, HG; Gaidano, G; Meyer, C | 1 |
| Croucher, PI; Karadag, A; Scutt, AM | 1 |
| Kurebayashi, J; Oka, T; Otsuki, T; Sakaguchi, H; Ueki, A; Uno, M; Yamada, O; Yata, K; Yawata, Y | 1 |
| Amiot, M; Bataille, R; Collette, M; Thabard, W | 1 |
| Croucher, PI; Drury, NL; Hargreaves, PG; Holen, I | 1 |
| de Nicolas, R; Egido, J; Gonzalez, E; Hernando, P | 1 |
| Attisano, C; Bianchi, A; Dianzani, U; Massaia, M; Peola, S; Pileri, A; Redoglia, V | 1 |
| Klein, B; Parant, MR; Vial, H | 1 |
| Bergui, L; Caligaris-Cappio, F; Campana, D; Chilosi, M; Janossy, G; Malavasi, F; Pizzolo, G; Tesio, L; van Camp, B | 1 |
| Cheung, HT; Du, ZJ; Liao, NS; St John, J | 1 |
| Dammacco, F; Miglietta, A; Perfetto, SC | 1 |
| Bataille, R; Commes, T; Jourdan, M; Klein, B | 1 |
23 other study(ies) available for tetradecanoylphorbol acetate and Multiple Myeloma
| Article | Year |
|---|---|
Nuclear organization of PML bodies in leukaemic and multiple myeloma cells.
Topics: Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Flow Cytometry; Gamma Rays; HL-60 Cells; Humans; Intranuclear Inclusion Bodies; K562 Cells; Leukemia, Promyelocytic, Acute; Melphalan; Multiple Myeloma; Tetradecanoylphorbol Acetate; Tretinoin; U937 Cells | 2008 |
Purification of functional eosinophils from human bone marrow.
Topics: Apoptosis; Azure Stains; Bone Marrow; Bone Marrow Cells; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Eosinophils; Flow Cytometry; Gene Expression; Humans; Interleukin-5; Interleukin-5 Receptor alpha Subunit; Multiple Myeloma; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Superoxides; Tetradecanoylphorbol Acetate; Time Factors | 2013 |
The survival of IL-6-dependent myeloma cells critically relies on their capability to transit the G1 to S phase interval of the cell cycle.
Topics: Animals; Apoptosis; bcl-X Protein; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; G1 Phase; Hybridomas; Interleukin-6; Leukocyte Common Antigens; Mice; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; S Phase; Signal Transduction; Tetradecanoylphorbol Acetate | 2005 |
1'-acetoxychavicol acetate is a novel nuclear factor kappaB inhibitor with significant activity against multiple myeloma in vitro and in vivo.
Topics: Adult; Aged; Apoptosis; Benzyl Alcohols; Caspase Inhibitors; Caspases; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Enzyme Activation; fas Receptor; Female; Humans; I-kappa B Proteins; Male; Middle Aged; Multiple Myeloma; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Kinase C; Terpenes; Tetradecanoylphorbol Acetate | 2005 |
Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
Topics: Apoptosis; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid; Microtubules; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; Tubulin Modulators; U937 Cells; Vinblastine | 2006 |
Spontaneous production of alpha- and beta-interferon in human lymphoblastoid and lymphoma cell lines.
Topics: Bromodeoxyuridine; Cell Line; Dexamethasone; Dimethyl Sulfoxide; Hematopoiesis; Humans; Interferons; Kinetics; Leukemia; Lymphocytes; Lymphoma; Multiple Myeloma; Tetradecanoylphorbol Acetate | 1982 |
Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Topics: Animals; Cell Line; Cytotoxicity, Immunologic; Female; Killer Cells, Natural; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiple Myeloma; Neoplasms, Experimental; Phorbols; Tetradecanoylphorbol Acetate | 1982 |
Phorbol myristate acetate induced neutrophil autotoxicity.
Topics: Cell Aggregation; Cell Line; Cell Survival; Female; Humans; Hydrogen Peroxide; Multiple Myeloma; Neutrophils; Ovarian Neoplasms; Oxygen; Phorbols; Tetradecanoylphorbol Acetate | 1980 |
Stimulus-specific defect in platelet aggregation in polycythemia vera.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Platelet Aggregation; Polycythemia Vera; Tetradecanoylphorbol Acetate | 1994 |
[Effect of lipopolysaccharide on cytosolic free calcium concentration in myeloma cells].
Topics: Animals; Calcium; Cytoplasm; Escherichia coli; Lipopolysaccharides; Mice; Multiple Myeloma; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.
Topics: Bone Marrow Cells; Dose-Response Relationship, Drug; Humans; Multiple Myeloma; Phenylalanine; Protease Inhibitors; Receptors, Interleukin-6; Tetradecanoylphorbol Acetate; Thiophenes; Tissue Inhibitor of Metalloproteinase-3; Tumor Cells, Cultured | 1998 |
Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.
Topics: Antibodies, Monoclonal; B-Lymphocytes; Burkitt Lymphoma; Cell Division; Cytokines; Gene Expression Regulation, Neoplastic; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Interleukin-10; Interleukin-6; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Virus Infections | 1999 |
Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor.
Topics: Alkaline Phosphatase; Antibodies; Bone Remodeling; Calcium; Cell Count; Cell Differentiation; Coculture Techniques; Collagen; Culture Media, Conditioned; Humans; Interleukin-6; Mesoderm; Multiple Myeloma; Osteoblasts; Receptors, Interleukin-6; Solubility; Stem Cells; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2000 |
Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells.
Topics: Aged; Bone Marrow; Breast Neoplasms; Cytokines; Female; Humans; Male; Middle Aged; Multiple Myeloma; Parathyroid Hormone-Related Protein; Proteins; Receptor, Parathyroid Hormone, Type 1; Receptors, Parathyroid Hormone; RNA; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Tumor Cells, Cultured | 2001 |
Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells.
Topics: Acetophenones; Antibodies, Monoclonal; Benzopyrans; Blotting, Western; Calcium; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Isoenzymes; MAP Kinase Signaling System; Microscopy, Fluorescence; Multiple Myeloma; Neovascularization, Pathologic; Phosphorylation; Protein Isoforms; Protein Kinase C; Protein Kinase C-delta; Protein Transport; Receptors, Interleukin-6; Subcellular Fractions; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2001 |
Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells.
Topics: Antibodies, Monoclonal; Cell Membrane; Flow Cytometry; Fluorescein; Humans; Immunohistochemistry; Isothiocyanates; Membrane Glycoproteins; Metalloendopeptidases; Multiple Myeloma; Protein Kinase C; Proteoglycans; Statistics, Nonparametric; Stimulation, Chemical; Syndecan-1; Syndecans; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2001 |
IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.
Topics: Cytochalasin B; Humans; Immunoglobulin A; Immunoglobulin Fab Fragments; Immunoglobulin G; In Vitro Techniques; Macromolecular Substances; Multiple Myeloma; Neutrophils; Platelet Activating Factor; Reference Values; Superoxides; Tetradecanoylphorbol Acetate | 1991 |
Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Topics: Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD3 Complex; CD8 Antigens; Histocompatibility Antigens; HLA-DR Antigens; Humans; Immunity, Cellular; Immunophenotyping; Interleukin-2; Ionomycin; Leukocyte Common Antigens; Leukocyte Count; Multiple Myeloma; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Tetradecanoylphorbol Acetate | 1991 |
Abnormal behavior of protein kinase C in the human myeloma cell line, RPMI 8226.
Topics: Animals; Brain; Cell Fractionation; Cell Line; Cell Membrane; Chromatography, DEAE-Cellulose; Cytosol; Humans; Kinetics; Multiple Myeloma; Phorbol 12,13-Dibutyrate; Protein Binding; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate; Time Factors | 1990 |
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Topics: Adult; Aged; Antigens, Differentiation, B-Lymphocyte; Antigens, Neoplasm; Antigens, Surface; Bone Marrow; Cell Differentiation; Cells, Cultured; Female; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Multiple Myeloma; Neprilysin; Phenotype; Plasma Cells; Tetradecanoylphorbol Acetate | 1985 |
Adhesion of lymphoid cell lines to fibronectin-coated substratum: biochemical and physiological characterization and the identification of a 140-kDa fibronectin receptor.
Topics: Animals; Calcimycin; Cations, Divalent; Cell Adhesion; Cell Differentiation; Cell Line; Cycloheximide; Cytochalasin B; Fibronectins; Humans; Lymphocytes; Lymphoma; Multiple Myeloma; Receptors, Fibronectin; Receptors, Immunologic; Tetradecanoylphorbol Acetate; Trypsin | 1987 |
Impaired chemiluminescence response by neutrophils in patients with multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Luminescent Measurements; Melphalan; Multiple Myeloma; Myeloma Proteins; Neutrophils; Oxygen Consumption; Paraproteinemias; Peroxidase; Prednisone; Tetradecanoylphorbol Acetate; Vincristine; Zymosan | 1986 |
Production of interleukin 2 in multiple myeloma.
Topics: Humans; Interleukin-2; Lymphocyte Activation; Multiple Myeloma; Phytohemagglutinins; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1986 |